Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.73 USD | -5.09% | -9.90% | +76.78% |
03/05 | Wedbush Adjusts Geron's Price Target to $7 From $6, Keeps Outperform Rating | MT |
02/05 | Geron Shares Decline After Q1 Loss Widens | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+76.78% | 2.21B | |
+9.15% | 106B | |
-1.08% | 104B | |
+7.37% | 23.25B | |
-11.55% | 22.5B | |
-7.19% | 18.7B | |
-37.08% | 17.95B | |
-9.91% | 16.99B | |
+7.55% | 14.26B | |
+40.04% | 12.76B |
- Stock Market
- Equities
- GERN Stock
- News Geron Corporation
- Geron Says First Patient Dosed in Early Trial of Imetelstat to Treat Bone Marrow Cancer